201 related articles for article (PubMed ID: 25137022)
21. Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer.
Tollens F; Baltzer PAT; Dietzel M; Schnitzer ML; Schwarze V; Kunz WG; Rink J; Rübenthaler J; Froelich MF; Schönberg SO; Kaiser CG
Eur Radiol; 2022 Nov; 32(11):7409-7419. PubMed ID: 35482122
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness Analysis of Breast Cancer Screening Using Mammography in Singapore: A Modeling Study.
Chootipongchaivat S; Wong XY; Ten Haaf K; Hartman M; Tan KB; van Ravesteyn NT; Wee HL
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):653-660. PubMed ID: 33531436
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
Ahern CH; Shen Y
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):718-25. PubMed ID: 19258473
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program.
Wang J; Greuter MJW; Vermeulen KM; Brokken FB; Dorrius MD; Lu W; de Bock GH
Breast; 2022 Feb; 61():58-65. PubMed ID: 34915447
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province.
Shi J; Guan Y; Liang D; Li D; He Y; Liu Y
Sci Rep; 2023 Feb; 13(1):3370. PubMed ID: 36849794
[TBL] [Abstract][Full Text] [Related]
28. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
[TBL] [Abstract][Full Text] [Related]
29. Risk stratification in breast cancer screening: Cost-effectiveness and harm-benefit ratios for low-risk and high-risk women.
Sankatsing VDV; van Ravesteyn NT; Heijnsdijk EAM; Broeders MJM; de Koning HJ
Int J Cancer; 2020 Dec; 147(11):3059-3067. PubMed ID: 32484237
[TBL] [Abstract][Full Text] [Related]
30. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.
Lord SJ; Lei W; Craft P; Cawson JN; Morris I; Walleser S; Griffiths A; Parker S; Houssami N
Eur J Cancer; 2007 Sep; 43(13):1905-17. PubMed ID: 17681781
[TBL] [Abstract][Full Text] [Related]
32. Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.
Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
GMS Health Technol Assess; 2010 Apr; 6():Doc05. PubMed ID: 21289878
[TBL] [Abstract][Full Text] [Related]
33. Using Risk Stratification to Optimize Mammography Screening in Chinese Women.
Leung K; Wu JT; Wong IO; Shu XO; Zheng W; Wen W; Khoo US; Ngan R; Kwong A; Leung GM
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377936
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study.
Hao S; Karlsson A; Heintz E; Elfström KM; Nordström T; Clements M
Value Health; 2021 Dec; 24(12):1763-1772. PubMed ID: 34838274
[TBL] [Abstract][Full Text] [Related]
35. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
Mital S; Nguyen HV
BMC Cancer; 2022 May; 22(1):501. PubMed ID: 35524200
[TBL] [Abstract][Full Text] [Related]
37. Cost effectiveness of mammography screening for Chinese women.
Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
Cancer; 2007 Aug; 110(4):885-95. PubMed ID: 17607668
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
39. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
[TBL] [Abstract][Full Text] [Related]
40. Breast Cancer Screening in Georgia: Choosing the Most Optimal and Cost-Effective Strategy.
Irzaldy A; Gvamichava R; Beruchashvili T; Sturua L; van Ravesteyn NT; de Koning HJ; Heijnsdijk EAM
Value Health Reg Issues; 2024 Jan; 39():66-73. PubMed ID: 37992568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
